i'm not losing weight on glp 1 If you find that you're Ozempic or other GLP-1 medications, your metabolism, or how quickly your body burns calories, may be the cause. It's sometimes called the “Ozempic 10 Reasons Why YOU Are

Yes, and that is exactly how most protocols work

The regulatory body maintains a 180-day standard review timeline for generic submissions, with potential approvals expected throughout 2026

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications

The least you can do is check in on them regularly

Now, Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes

Phase I and II clinical trials corroborate these findings, showing dose-dependent weight loss, reductions in Glycated Hemoglobin (HbA1c) levels, and improvements in liver steatosis and diabetic kidney disease